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Abstract
Tissue engineering has offered wide technologies for developing functional biomaterials 
substitutes for repair and regeneration of damaged tissue and organs. Biomimetic mate-
rials with their inherent nature to mimic natural materials are possible through the recent 
advances in the fabrication technology. With the help of porous or dense implants made 
with biodegradable materials, it is possible to incorporate different vital growth factors, 
genes, drugs, stem cells and proteins. In this review, we presented various fabrication 
methodologies of biomimetic and bioactive scaffolds for tissue engineering applications. 
An overview of the nanocomposites of biomaterials is presented. Further an example of 
one of the hybrid nanocomposite material is given for additive manufacturing.
Keywords: biomimetic scaffolds, bioactive ceramics, fabrication technology, tissue 
engineering, 3D printing
1. Introduction
Inspired by the natural evolution mechanisms and their structural, physical and chemical 
characteristics of biological organisms, researchers worldwide are looking for synthetic mate-
rials that mimic the function of the natural materials. Nature offers solutions to many complex 
technological and materials solutions due to the billon of years of technological evolution. 
Biomimetics [1] is considered as a future of materials design and productions. The history 
of biomimetics exploration by humans dates back to early fifteenth century by Leonardo da 
Vinci speculating the clues of possibility of human air travel following the mechanics of flight 
of birds. Biomimetic materials have potential applications in various domains such as biology, 
chemistry, materials science and electronics. In the present scenario, the need for synthetic bone 
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substitutes [2] in the last few decades have increased owing to the number of accidents/trauma 
and inherent bone defects. The current state-of-art enables the successful fabrication of the 
materials [3] for biomimicking applications especially for biological applications. Mimicking 
the 3D structure and extracellular matrix (ECM) [4] of native tissue is critical for successful 
cell transplantation and growth of artificial tissue. Biomimetic scaffolds are therefore neces-
sary to recapitulate this natural environment and provide various cues to direct cell processes 
and differentiation. For examples, when considering a biomaterial to be used in implants or 
bone grafts, various aspects such as biocompatibility, osteogenic properties, bioactivity and 
its mechanical functions, based on its functionalities have to be studied. To replicate an ideal 
scaffold as biomimetic for tissue applications, fabrication methodologies play a very major 
role. Especially, tissue engineering has a great promise in using the biomimetic technologies 
for organ transplantation [5], reconstructive surgery [6] and artificial extracellular matrices [7] 
for three dimensional tissue formation. In the field of tissue engineering various approaches 
are followed such as cell substitution for specified functions, delivery of induced substances 
such as cell growth and differentiation and growth of cells in three dimensional scaffolds. 
Bone reconstruction is clinically important due to the large number of patients who have bone 
defects of critical size, leading to decrease in overall health and quality of life. The main treat-
ment for bone defects remains bone grafting [8]. Approximately, 600,000 bone graft proce-
dures are performed each year in the United States, and about 2.2 million of such procedures 
are performed worldwide annually, generating a sale of about 2.5 billion dollars per year and 
representing the second most common tissue transplantation procedure after blood [9–13].
There are a variety of scaffold fabrication methods in tissue engineering, including gas foam-
ing, solvent casting and particulate leaching, emulsion freeze-drying, phase separation, melt 
molding, membrane lamination, electrospinning, fiber bonding, polymer/ceramic composite 
foam fabrication or a combination of these techniques [9, 14–16]. In order to replicate the 
natural bones, scaffolds are engineered to be bioactive or bioresorbable to enhance tissue 
growth. Scaffolds are often porous that supports mechanically. There are various criteria such 
as biocompatibility, mechanical properties, pore size and bioresorbability that have to be con-
sidered as requirements of an ideal scaffold. Different classes of materials are used for fabrica-
tion of scaffolds such as polymers, bioglass, composite and metals. Significant progress was 
achieved in terms of scaffolds for mechanical support with better osteogenesis and angiogen-
esis. Various material fabrication methodologies enable the possibility to fabricate scaffolds 
with complex design [17] to ensure mechanical integrity and scaffold interconnectivity. The 
objective of this chapter is to review the different fabrication methodologies and the recent 
advances in the fabrication of biomimetic and bioactive scaffolds are presented with a case 
study and the possible improvements envisaged are discussed.
2. Biomimetic nanocomposites types and fabrication methodologies
2.1. Various biomimetic nanocomposites based on their design
Human body being a complex and sensitive biological system requires the scaffold materi-
als with diverse and challenging characteristics. Scaffold must combine structural, material, 
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bioactivation, signaling molecules, cells and biological requirements satisfied for different 
applications. Human bone [18] is classified as the long bones (femur and tibia), short bones 
(vertebrae and metacarpal bone), flat bones and the spongious bone [19]. The structural prop-
erty of the corresponding bones is strongly interdependent on the mechanical property [20]. 
The cortical bone contains 10% porosity and is mostly dense, whereas the spongy bones are 
highly porous and has less mechanical property. The spongy bones act as a host to soft tissues, 
cartilage, and meniscus and prevent the stress concentration. The fibrous tissue surrounding 
the bones is ligaments, which are highly organized fiber tissue composed of collagens, elastin, 
proteoglycan, water and cells. The mineral inorganic part will be assisting in compression and 
shear and the collagen matrix provides tensile strength. Anisotropic compact bone has com-
pression strength in the range of 130–225 MPa along the longitudinal direction and has the 
compression strength in the range of 105–135 MPa in transverse direction [21]. The cancellous/
spongy bone has compression strength of 5–10 MPa and elastic modulus of 50–100 MPa. In the 
current state of art, it can be observed that the mechanical integrity of the synthetic scaffolds 
is inadequate. Polymers have yielded results close to the cancellous bone properties. Bimodal 
architectures [22] matching the natural bone is yet in progress. Scaffolds should provide suffi-
cient strength [23] for cell ingrowth in in vitro conditions and integrate completely under in vivo 
conditions. In order to fabricate the biomimetic materials various systems [24] such as poly-
saccharides, proteins, nanocomposites based on calcium phosphates (CaPs) (e.g., β-tricalcium 
phosphate, hydroxyapatite) with good osteoconductivity, resorbability and biocompatibility 
are employed. The polymers [25] employed usually assist in structural integrity and promotes 
cell adhesion. Whereas, CaPs are biocompatible, osteoconductive and biodegradable with limi-
tations on mechanical strength that forbids the load-bearing applications. β-TCP is the high 
temperature phase of CaPs, but has the chemical similarities with HAp, with different resorb-
ing capability [26]. Resorption of HAp is slow in the biological medium and β-TCP has good 
reabsorption. Ionic co-substitutions in calcium phosphates are also used that can influence the 
structure, microstructure, crystallinity and dissolution rate. Various ions [27] such as Sodium, 
Strontium, Magnesium, Manganese, Silver, Barium Potassium, Zinc, Fluoride, Chlorides and 
Carbonates are substituted in hydroxyapatite. The substitution of these aforesaid ions have sig-
nificant role in causing alterations to bone resorption, bone formation, solubility, structure and 
morphological changes and enhanced surface microstructure. There are also Calcium phos-
phate based cements [28] that can be used as injectable pastes in the defect bone site for cell 
delivery and is an upsurging topic of research. Nanocomposites [29] consisting the component 
of polymer and nanosized CaPs improves the tissue bonding, cell adhesion and cell differentia-
tion. Designing of the 3D scaffold [30] should stimulate the adhesion, proliferation and differ-
entiation mechanisms in addition to the structural complexity of natural bones. The synthetic 
bone should also enable vascularization to enable biointegration with transport and support 
of signaling molecules, passage of nutrients and blood vessels. Hence the critical aspects such 
as highly porous interconnected microstructure and degree of porosity for uniform cell dis-
tribution, proliferation and migration in vitro. Critical pore sizes [31] are necessary to adjudge 
their function, because when the pore size is small the cell adherence can block the pores and 
matrix formation of the scaffold. An optimal pore size of ~150–400 μm can help in bone tissue 
regeneration. On the other hand, the high porous scaffold will have low Young’s modulus 
and compressive strength. It was reported that the tangent elastic modulus of natural bones 
decreases with the increase in porosity such as in porous tantalum [32]. The Young’s modulus 
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value of wet compact bone is in the range of 6–11 GPa, a porous scaffold of Ni-Ti with porosity 
in the range of 20–50 Vol % was fabricated by powder metallurgy.
Equally the pore shape, size and orientation are important in adjudging the mechanical prop-
erties of the scaffolds. Variation of the mechanical properties [33] of the scaffold with two 
different pore structures was reported earlier. It was observed that the mechanical properties 
of the scaffold with spherical pore structure have higher elastic modulus in comparison to the 
scaffold with cylindrical pore [34]. Similar alteration in the mechanical properties was also 
reported in the case of polycaprolactone [35]. From the aforesaid it can be concluded that the 
mechanical properties of the fabricated scaffold can be altered by the variation of the pore 
shape. Similar influence was reported on the pore size, where an increase in the pore size 
reduces the mechanical properties. The orientation of the pores also significantly altered the 
mechanical properties of the scaffold irrespective of the matrix of the material chosen ranging 
from metals to polymers. When the pore geometry was parallel or aligned in the same direc-
tion, the mechanical strength of these scaffolds were high. The mechanical stability of the 
multiscale porosity can be interesting in terms of crack propagation. This multiscale porosity 
can be achieved by combining two or three scaffold fabrication methods.
2.2. Materials for fabrication of scaffolds
Materials for fabrication of scaffolds [36] are selected based on their degradability, chemi-
cal and physical properties. Materials can be classified based on their source and mode of 
origin/preparation. Animal and plant based materials such as starch, alginate, chitosan, hyal-
uronic acid, gelatin, collagen, fibrin, silk, etc., are used as natural biomaterials. Due to the 
disease transmission and purification, synthetic biomaterials are attracting the interest of the 
researchers. Synthetic organic and inorganic materials such as HAp, CaPs, glass, polyesters 
are actively studied for usage as scaffold material. Autograft bone scaffold [37] was consid-
ered to the gold standard for bone repair defect. Lack of donors and possible disease infection 
are few of the major disadvantages of autograft scaffolds. Bone allograft [38] was considered 
as an alternative to the autograft, but still the transmission of diseases, inflammatory reac-
tions and rejection by the recipient body is prevalent. Hence artificial scaffolds have been pro-
posed as an alternative to the autograft and allograft scaffolds. Usage of metallic implants [39] 
dates back to 1920. Currently synthetic bone implants made of metals, ceramics, composites 
and glasses are employed for bone regeneration and bone reconstruction. There are several 
issues such as poor strength of the polymer scaffolds, poor ion release of ions from the metal-
lic scaffolds, brittleness of the ceramics and difficulty in controlling degradation rate of the 
composite scaffold to be addressed. Langer and Vacanti [40] were the pioneers of the tissue 
engineering concept in early nineties. They introduced the concept of introducing the bone 
marrow cells, different growth factors, gene and drug delivery in to the artificial bone scaf-
folds. Further investigations by various researchers enabled the possibility of improving the 
biocompatibility by changes in the topology, nanostructure, chemistry and structural aspects 
of the scaffolds. Metallic biomaterials are especially preferred for their usage in load-bearing 
applications due to their good mechanical properties. The porous metallic scaffolds [41] based 
on the stainless steel, titanium and magnesium are used to eliminate stress shielding and 
reduce the stiffness to match the natural bone. Interconnected porous metallic scaffolds [42] 
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were fabricated by combining the various rapid prototype techniques such as solvent leaching 
and 3D printing was reported in the fabrication of Ti scaffolds. Other fabrication techniques 
such as powder metallurgy, sintering and rapid prototyping to modulate the scaffold design. 
The mechanical properties of the Ti scaffolds can be used to mimic the human cancellous bone 
due to its structural flexibility. The elasticity and other vital properties such as deformation 
force, stress and strain can be modified by alloying with a suitable metal. NiTi alloys were 
reported to exhibit good in vivo compatibility than pure Ti porous scaffolds [43]. The porous 
metallic scaffold assisted in rapid formation of new bone tissues for load-bearing conditions.
Bioactive glasses [44] were reported to have good osteoconductivity, controlled biodegradabil-
ity, cell delivery capabilities and inducing osteogenic gene expression for formation of bone 
minerals and capability for drug delivery. But bioactive glasses yield poor results for load-
bearing applications due to their lack of superelastic performance, mismatch of compressive 
strength and Young’s modulus of the natural bone. In order to improve the mechanical prop-
erties of the bioactive glasses, modification of structure and composition is achieved during 
bioglass scaffold fabrication. Biomorphic and mesoporous bioactive scaffolds [45] were shown 
to have better mechanical properties than in comparison to the classical bioactive glasses. The 
inorganic component phase in the bioactive glass scaffold is important in addition to the struc-
tural design of these bioactive glass scaffolds. Biopolymers and its derived composites are 
also used for fabrication of scaffold for tissue engineering applications. However their poor 
mechanical strength makes it difficult to use them in load bearing applications. Biopolymer 
based composites and hybrids for bone scaffold applications [46] with required strength are 
prepared by varying the volume fraction of polymer in the composites. ECM structure [47] pro-
vides the structural and biochemical support, hence ECM like biopolymers, ECM-HAp com-
posites and ECM bioglass scaffolds are studied for tissue engineering applications. In order 
to replicate the biomimetic conditions, surface modifications are also carried out. Controlled 
release of biological molecules is also a key function that the scaffolds play.
2.3. Biomimetic porous scaffolds
Porous biomimetic scaffolds [48] with their 3D structure is advantageous for (1) better cell bio-
material interactions, cell adhesion and growth (2) interconnected porosity for angiogenesis 
and transport of nutrients, regulatory factors for cell survival, proliferation and differentiation 
(3) Sufficient structural integration with good tensile strength and elasticity (4) Control deg-
radation and minimal toxicity in vivo. Nanocomposites of CaPs and natural polymers such as 
collagen and gelatin are well known for tissue engineering. Techniques such as foam replica 
method [49], freeze casting [50], freeze drying [51], phase separation [52], gas foaming [53], 
rapid prototyping [54] and electrospinning [55] are employed for fabrication. The challenge 
of nanocomposite scaffolds lies in the ensuring the retention of chemical phases and retaining 
the porous structure without disturbing their porous structure. A combination of different 
method of fabrications such as freeze casting and electrospinning are used for fabrication of 
scaffolds. Other polymers such as poly lactic co-glycolic acid (PLGA), Sodium dodecyl sulfate 
(SDS), cellulose, poly glycolic acid (PGA), poly (ethylene glycol) and poly l-lactic acid (PLA) 
are also used for fabricating the nanocomposites due to their excellent biodegradability and 
biocompatibility. Collagen of type I, the predominantly available protein in mammals can be 
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readily obtained from animal tissues and from human tissues. This extracellular matrix pro-
tein collagen can be reconstituted in a different morphology into fibrillary matrix by changing 
the pH and temperature of precursors. Due to the lack of mechanical strength in collagen for 
in vivo applications, several strategies are employed such as crosslinking with hydrogels [56] 
or compression so that it can sustain or resist cell-induced contraction. Inherent characteris-
tics of collagen such as dipole moment and alignment under strong magnetic field [57] were 
demonstrated to induce cell migration and allow preferential growth of neurites along the 
alignment of the fibril direction. Collagens can hold several cellular receptors that can vari-
ate the cell behavior and their biological function can be induced by combining with growth 
factors for example, vascular endothelial growth factor (VEGF) to improve cardiac function 
was observed.
Fibrin [58] is a specialized protein network clinically available from autologous sources such 
as human blood plasma. In the presence of thrombin protease, fibrin matrix is formed spon-
taneously by polymerization of fibrinogen. Cell migration in fibrin is dependent on the cell-
associated proteolytic activity from plasmin and MMPs due to their small diameter. This 
indeed assists in strong fibril-fibril interaction and the natural network formation and stabili-
zation through covalent bond stabilization. As fibrin matrices are poorly active for most of the 
cell types, functionalization with ECM peptides or growth factors is necessary. The controlled 
release of the growth factors and hormones can be efficiently done by covalent bonding of 
biomolecules. This possibility of delayed/controlled release of the growth factors/hormones 
[59] is currently employed for clinical evaluation for local bone repair.
Hyaluronan or Hyaluronic acid [60] is a structural protein that is noncovalently attached to 
the protein core and entwine ECM. Due to their strong anionic nature, these polymers absorb 
water and hence providing the compressive strength to the ECM. Various chemical hyal-
uronic acid derivatives have been prepared by controlling the functional group and the type 
of covalent bond. It is possible to create a wide range of materials with diverse properties. 
Hyaluronic acid [61] is used for various applications for dermal wound healing, chondrocyte 
transplantation for tissue repair and for incorporation of other functional biomolecules for 
improved fibroblast proliferation and wound healing. Other self-assembling polypeptides 
are also used to form nanofibrillar matrices in situ. Self-assembled peptide hydrogels [62] are 
used as a tool for developing 3D cell culture plates.
To have properties similar to natural ECM, it is necessary to have facilities for cell seeding, 
adhesion, proliferation, differentiation and new tissue generation. Essential characteristics 
such as biodegradability and mechanical properties are important to be studied. The bio-
degradation of the scaffold should be in coherence with the rate of the formation of the new 
tissue formation that it supports initially to act as a scaffold material to serve as a template. 
Elastomeric properties of scaffolds [63] are studied to improve their applications in tissue 
engineering applications. Other than the natural ECM materials, synthetic polymers such as 
poly (ɛ-caprolactone) (PCL) and polyurethanes (PU) [64] are investigated for vascular and 
other tissue engineering applications. Tensile modulus and strength are critical parameters 
necessary for tendons and ligaments. Natural fibrous protein from silk worm cocoon is a 
Scaffolds in Tissue Engineering - Materials, Technologies and Clinical Applications8
material with excellent tensile and mechanical strength [65]. Though Sericin present in the 
natural silk causes adverse immune responses and is disadvantageous for tissue engineering 
applications, natural silk’s biocompatibility is improved upon Sericin removal. Silk fibroins 
have hydrophobic and hydrophilic blocks which forms crystals through hydrophobic inter-
actions and hydrogen bonding resulting in the improved tensile strength. Spider silk fibroin 
polymers [66] are used for genetic engineering due to their excellent mechanical and cell 
adhering capacity.
As extracellular proteins have a fibrous structure with diameters in the nanometer or sub-
micrometer scales, various advanced material shaping techniques were developed. Techniques 
such as electrospinning, self-assembly and phase separation are a few worthy-to-mention. 
Electro-spinning technique were used to produce nanofibers, but the disadvantage of this 
technique is to fabricate the complex 3D scaffold structure or to produce intricate pore struc-
tures. Various cells were reported to proliferate, differentiate and attach on these electro-spun 
nanofibers [67]. Phase separation arises when homogeneous multicomponent system tends to 
be unstable resulting in multiphase system due to the system free energy. This technique is 
employed in generating porous structures as tissue engineering scaffolds. The physical form 
of the porosity (closed/open) depends on the system of phase separation. The huge disad-
vantage of this technique is the lack of interconnected porosity and the lack of control over 
3D shapes. Biological effects of nanofibrous scaffold [68] were found to adsorb more human 
serum proteins in comparison to the scaffolds of smooth pore wall morphology. The cell adhe-
sion proteins were comparatively well detected than the conventional scaffolds.
Hydroxyapatite being the major inorganic compound used in most of the composite scaffolds, 
it provides good osteoconductivity. In the presence of the composite structures with poly-
mers hydroxyapatite provides structure and design flexibility. Further it assists in improving 
the protein adsorption capacity, microstructure favoring the bone tissue regeneration and 
diminishing the cell death. These nanocomposites mimic the features similar to the natural 
bone with improved mechanical properties. However regarding the biodegradation rate of 
stoichiometric HAp are less efficient than the partially carbonated apatite. The surface of scaf-
folds affect cellular response and in turn also the tissue regeneration [69].
2.4. Biomimetic scaffold fabrication
Composites of scaffold materials with organic and inorganic components were designed 
for mechanical and physiological requirements in tissue engineering. However the brittle 
nature of ceramics and low mechanical strength inhibits their usage in clinical applications. 
Composite structure of HAp with porous polymers alongside their pore size, shape and 
morphology has improved the mechanical strength for tissue engineering applications. With 
the recent advances in the biodegradable polymers [70], glass and ceramics, it is possible 
to cater degradation kinetics and resorption in vivo after stimulating cellular responses at 
the molecular level. It is expected that the new generation of scaffolds can perfectly mimic 
the natural bone in terms of mechanical and structural aspects. With the advances in the 
manufacturing techniques such as selective laser sintering and rapid prototyping should 
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be helpful in bone tissue engineering applications. These techniques are widely used in the 
fabrication of temporomandibular joints [71], craniofacial [72] or periodontal structures [73]. 
The fabrication methodology allows the flexibility of the combination of different materi-
als for increasing mechanical strength. The current state-of-art, however, does not allow 
to exactly replicate the natural architecture of the extracellular matrix or the natural bone. 
There is a continuous demand for the improvement and functioning of the scaffold fabrica-
tion. Here we will discuss few of the fabrication techniques such as solvent casting, particu-
late leaching electrospinning, gas foaming, phase separation, fiber meshing and bonding, 
self-assembly, rapid prototyping, melt molding, lamination and freeze drying.
2.4.1. Solvent casting
A nineteenth century technology, which was initially used for production of thin films, is cur-
rently employed for diverse applications ranging from optical applications, photographical 
film base flexible printed circuits and high temperature resistive films. Solvent casting [74] 
are generally produced by evaporation of the solvent in order to form the scaffolds. In order 
to successfully employ the solvent casting, it is necessary that the polymer used should be 
soluble in a volatile solvent or in water. A stable solution with an adequate solid content and 
viscosity should be formed. Formation of homogeneous film after removing from cast sup-
port must be possible. The main disadvantage of this technique is the denaturation of the pro-
tein caused due to the solvent if toxic and influence of the organic material on the solvent. To 
remove the toxicity of the solvent left over in the scaffold, they are usually dried by vacuum 
process and dried completely. To make it time efficient, other techniques such as particulate 
leaching were combined for the fabrication of scaffolds.
2.4.2. Particulate-leaching technique
Being one of the popular techniques in the fabrication of scaffolds for tissue engineering [75] 
is relatively a technique of ease. Usage of porogens such as salt, sugar and wax is common to 
produce the pore channels by this technique. Mixture of porogen of the desired size is mixed 
with the material, then after leaching the porogen, the pores are left behind in the matrix. 
The control of the pore size is possible by choosing the required size and shape of the poro-
gen. Pore sizes in the range of 300–500 μm is possible with a porosity percentage of around 
94–95%, however the control of the interconnected pore is not possible. Thin layers of up to 
3 mm thickness is feasible with this technique.
2.4.3. Gas foaming
Gas foaming process uses the utilization of high pressure gases for the fabrication of highly 
porous scaffolds [53]. While the polymers are used, they get saturated and gets nucleated as 
a gas bubble with the gas bubble size ranging in the order of 100–500 μm are used. When the 
gas is injected the gas bubble starts to create the phase separation. A three dimensional porous 
structure can be obtained by using the gas foaming technique. But the control over the inter-
connectivity is highly lagging behind in this technique, though is advantageous in terms as a 
solvent free technique. The porosity will be frequently absent on the external surface.
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2.4.4. Phase separation
This technique involves quenching of the polymers which can cause two phases of polymers 
to separate as polymer rich and polymer poor phases [76]. The polymer poor phase will cause 
the porous structure network to be formed. The control of the porous microstructure is pos-
sible with the help of parameters such as polymer concentration, quenching rate and temper-
ature, solvent concentration, solvent type and dispersion of the solute molecules. The solvent 
can be removed by extraction, evaporation and sublimation after integrating the bioactive 
molecules in the scaffold. Nanofibers can be prepared by liquid-liquid phase separation to 
replicate the architecture similar to type I collagen molecules and other extracellular matrix 
architectures for 3D cell culture environment. As these experiments are carried out at low 
temperatures, the incorporation of bioactive molecules is feasible. The phase separation meth-
odology can be used in conjunction with other techniques that can control the porous archi-
tecture and also with other rapid prototyping techniques for tissue engineering applications.
2.4.5. Sintering/heat molding
This technique [77] involves filling the mold with the mixture of powder/polymer and porogen 
and heating/sintering above the glass transition temperature of the polymer or at the porogen 
evaporation or melting temperature. The external shaping of the sample will take form of the 
die set up/mold used for sintering or heat molding. When the porogen is leached out and then 
the scaffold is formed. The inconvenience of this technique is that the possibility of residual 
porogen and impossibility to incorporate biological molecules due to the involvement of high 
temperature processing.
2.4.6. Freeze casting
This technique [78] involves the mixing the solvent and the solute followed by decrease of 
temperature until to reach negative temperature to fabricate ice crystals. The solute mol-
ecules are segregated around the ice crystals forming a porous network. In order to remove 
the solvent, lyophilization is carried out which involves applying lower pressure than the 
equilibrium vapor phase of the frozen solvent. After sublimation of the solvent ice crystals, 
the porous network remains intact. The beneficial factors of this technique is the possibil-
ity of changing the morphology of the pores by modulating the temperature of ice crystals 
and the possibility to incorporate bioactive molecules due to the low processing temperature 
involved in this fabrication methodology. The pore size distribution and the homogeneity 
of the porosity formed can be controlled with the aid of the processing temperature of the 
process. Freeze casting can also be used to protect other dry biological samples to retain their 
bioactivity.
2.4.7. Fiber Mesh
This technique [79] involves interweaving or weaving individual fibers into a three dimensional 
scaffold with varying pore size. This technique enable the availability of the cell attachment 
and allows transport of the nutrient for the cell survival and cell growth. Though the practical 
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difficulties such as lack of structural stability exists. In order to increase the structural stability 
and increase the crystallinity heat treatment is sometimes employed to overcome the structural 
instability in Fiber Mesh technique.
2.4.8. Fiber bonding
This technique [80] involves combining the nonfiber polymer mixing with a solvent, when the 
solvent is removed then the solute molecules will be embedded in the polymer matrix. The 
scaffolds are fabricated by bonding the collagen matrix to polymers with threaded collagen 
fibers. The fiber bonding encapsulation takes place due to the heat treatment. The resulting 
scaffold structure has large surface area that allows the cell proliferation by replicating the 
extracellular matrix. The disadvantage of this technique involves the poor controlling ability 
of the porosity and the pore size, unavailability of suitable solvents and appropriate melting 
temperature of the polymers.
2.4.9. Electrospinning
This technique [81] is highly used for fabricating the nanofibrous architecture. Nanofibrous 
architecture highly favorises cell binding and other cell behavior activities. Electrospinning 
was successfully employed in fabricating porous scaffolds of nano- and microscale fibers 
that can replicate the structural and biological functions of the natural extracellular matrix. 
The method involves electrostatic spraying of polymer coatings. Scaffolds with >90% were 
obtained by this methodology. An appropriate solvent is required for dissolving the poly-
mer to be loaded in a syringe. The rate of control of polymer flow can be adjusted by constant 
syringe flow rate. Various parameters are necessary for scaffold fabrication by electrospin-
ning such as viscosity, conductivity, molecular weight and surface tension of the polymers 
and the processing parameters such as applied voltage, flow rate and temperature. The 
main advantage of this technique is that it can produce 3D scaffold configuration adaptable 
for cell and tissue organization, adhesion and spatial cell regeneration with suitable physi-
ological conditions. The main disadvantage of this technique is the impossibility of cell 
seeding, but cryospinning and templated sacrificial scaffold can create the pore of desired 
size in the electrospun matrices. Electrospinning is also used in conjunction with other scaf-
fold techniques such as solvent casting and rapid prototyping techniques. Favorable results 
were observed in cell culture for cartilage and bone tissue engineering applications with 
electrospun scaffolds.
2.4.10. Rapid prototyping
The group of techniques [82] involving the assistance of computer assisted design (CAD) and 
computer assisted manufacturing (CAM) such as stereolithography, selective laser sintering, 
fused deposition modeling, three dimensional printing and three dimensional plotting. The 
choice of materials ranges from polymers, ceramics to metals. These fabrication techniques are 
frequently used for fabrication of biomimetic tissue scaffolds. Most of these techniques are capable 
of yielding scaffolds with good mechanical strength, high accuracy and possibility of incorpora-
tion of cells and proteins. There are few limitations such as elevated temperatures, weak bonding 
Scaffolds in Tissue Engineering - Materials, Technologies and Clinical Applications12
between the powder particles, trapped powders in the pores (requiring post treatment measures) 
and slow fabrication processing in few cases. These materials are prevalently employed in bone, 
heart valves, adipose tissues and cartilages. Hybrid materials based on calcium phosphates with 
polymers is also widely used with rapid prototyping also known by terminology as additive 
manufacturing. In the following section, we will focus on one of the widely used rapid prototyp-
ing technique called as 3D printing with an elaborate example as a case study.
2.5. Hybrid materials based on calcium phosphates and polyurethanes for bone tissue 
engineering – a case study
Additive manufacturing (AM), also known as rapid prototyping or solid freeform fabrica-
tion, was developed in the mid-1980s as an advanced technology to overcome the limitations 
of these conventional methods and have received much attention in recent years due to its 
ability to deliver a high level of control over the architecture of the construct [13]. With AM 
techniques, scaffolds with precise geometries can be prepared, using computer-aided design 
combined with medical imaging techniques (either computed tomography – CT, scanning or 
magnetic resonance imaging – MRI) to make anatomically shaped implants [83].
According to ISO/ASTM52900-15, there are seven categories of ALM type processes: Binder 
Jetting, Directed Energy Deposition, Material Extrusion, Material Jetting, Powder Bed Fusion, 
Sheet Lamination and Vat Photopolymerization [84]. AM techniques may be divided into three 
sub-groups: (1) laser or other directed energy beam, (2) print or “ink,” and (3) nozzle systems 
[85]. C.K. Chua and W. Y. Yeong have classified AM techniques for the fabrication of tissue 
scaffolds in two types of methods: (1) direct methods and (2) indirect methods [16], summa-
rized in Table 1.
Several Rapid Prototyping (RP) techniques, such as selective laser sintering (SLS), fused deposition 
modeling (FDM), precision extrusion deposition (PED) and 3-D fiber deposition (3DF) have been 
used to fabricate polymer–calcium phosphate composites based on poly(hydroxybutyrate-co-
hydroxyvalerate), PLLA, PCL or poly(ethylene oxide terephthalate)/poly(butylene terephtalate) 
(PEOT/PBT) co-polymer and different calcium phosphates, such as carbonated hydroxyapatite, 
HA or β-tricalcium phosphate (β-TCP) [85].
In 2014, Zhou et al. [86] proposed a new method to increase the printability of calcium phop-
shate powders, by mixing it with CaSO
4
 (HA: CaSO
4
 = 25:75 weight ratio) for scaffold fabri-
cation through 3D printing method. 3D printing technique has been used for fabrication of 
3D scaffolds based on hydroxyapatite (HA) and organic polymers such as polyvinyl alcohol 
(PVA) [87] or collagen [88].
A scaffold made of composite material based on calcium phosphate and collagen was obtained 
by 3D printing method at low temperatures. For this purpose, 5–20% phosphoric acid was used 
as binder and Tween 80 was added as a non-cytotoxic surfactant in the proportion of 0.25% 
in the binder solution. The optimal concentration of the binder solution (8.75%) for which the 
cytocompatibility and mechanical strength are maximized has been established. Collagen has 
previously been dissolved in the binder solution to further enhance the fabrication of calcium 
phosphate-collagen composites by 3D printing.
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In 2013, Nandakumar et al. [88] reported the production of two types of polymer-hydroxyapatite 
composite scaffold by 3D deposition using a Bioplotter. PolyActive ™ (PA), a commercial copo-
lymer of poly (ethylene oxide-terephthalate)/poly (butylene terephthalate) (PEO/PBT) was used.
In the first embodiment, polymer-ceramic composite filaments with the desired mass ratio 
(maximum 15% HA) were extruded and further used for scaffold fabrication using a Bioplotter. 
In the second approach, polymer scaffolds were obtained by 3D deposition, while the ceramic 
particles were made in the form of columns by sintering the ceramic paste through stereo-
lithography. The two components were then manually assembled by pressing HAp into the 
pores of the polymer scaffold, thus creating the composite material.
Among 3D printing techniques, bioplotting is the most used method in printing of 3D tissue 
constructs. Bioplotting, first developed in 2000 at the Freiburg Research Centre, is an extru-
sion-based printing method that is spatially controlled by a robotic system (x, y, and z direc-
tions) with microscale resolution, which uses STL files to guide the extrusion head. Nozzles of 
various diameters are used for dispensing highly viscous or pasty materials applying differ-
ent actuation mechanisms – mainly screw – or piston based mechanical and pneumatic. The 
dispensing head moves in three dimensions, while the fabrication platform is stationary. The 
printed construct from the bioplotter occurs in a laminar fashion by the computer-controlled 
deposition of material on a surface and could be relatively large (several centimeters in length, 
width, and height) [82, 89].
Type of method
Direct Indirect
Melt-dissolution deposition 
techniques
Particle bonding techniques
Fused deposition modeling (FDM) Selective laser sintering (SLS) Droplet deposition
Precision extruding deposition (PED) Three dimensional printing (3D 
printing) or color jet printing (CJP)
Melt deposition
3D fiber deposition technique (3DF) TheriForm Photo-polymerization: 
– stereolithography 
– two-photon polymerization
Precise extrusion manufacturing (PEM)
Low-temperature deposition 
manufacturing (LDM)
Multi-nozzle deposition manufacturing 
(MDM)
Robocasting
Pressure-assisted microsyringe (PAM)
3D bioplotter
Rapid prototyping robotic dispensing 
system (RPBOD)
Table 1. Classification of additive manufacturing (AM) techniques for scaffold fabrication.
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Since heating is not required, the system can process thermally sensitive biocomponents, and 
even cells. The strand thickness can be modulated by varying material viscosity, deposition 
speed (speed in the planar field), tip diameter, or the applied pressure. The main advan-
tages of bioprinting using a Bioplotter system are the room temperature processing, direct 
incorporation of cells, and homogenous distribution of cells. The main disadvantages are 
limited mechanical stiffness, critical time of hardening, specific matching of material, and 
low resolution [90].
2.5.1. Fabrication of 3D scaffolds based on hydroxyapatite-polyurethane hybrids
Hydroxyapatite—polyurethane 3D scaffolds have been obtained using system BioScaffolder 
SysEng, Germany, (Figure 1) connected to a computer on which the Bioscaffolder SW version 
3.0 software is installed.
HAp-PU nanostructured hybrid powders synthesized in high pressure hydrothermal 
conditions (1000 bar and 100 bar, respectively) were mechanically mixed with a carefully 
selected commercial polymer (Mowiflex, Kuraray Poval) 20% solution, and a crosslinking 
agent (Baymedix® FD103, Covestro), to obtain HAp-PU-based pastes used as a feedstock in 
the 3D Bioprinting technique. Some examples of 3D hybrid structures obtained with differ-
ent nozzles and rotation angle between 2 successive layers (90° and 45°, respectively) are 
given in Figure 2.
2.6. Hydrothermal synthesis of hybrid organic-inorganic nanostructures in high  
pressure conditions
Hydrothermal method is a well-known and attractive technique for producing pure nano-
crystalline, highly homogeneous nanoparticles in a single step, in aqueous medium, with low 
energy consumption [91–94]. The hydrothermal method has proven to be an effective, con-
venient and environmentally friendly process. Hydrothermal synthesis at high pressure is 
characterized by three main advantages: (i) low energy consumption, developed by applying 
Figure 1. (a) System BioScaffolder, SYSENG and (b) low temperature deposition head.
Fabrication Methodologies of Biomimetic and Bioactive Scaffolds for Tissue Engineering...
http://dx.doi.org/10.5772/intechopen.70707
15
pressure (for a liquid phase, the same energy is involved on five units for the temperature 
scale than on 4000 units for the pressure scale); (ii) negative ΔV value between the total molar 
volume of reaction products and the total molar volume of reactants and (iii) improvement of 
the chemical reactivity.
2.6.1. Hydrothermal synthesis at 100 bar using Ar gas
In a first step, Ca(NO3)2*4H2O (Sigma Aldrich) was dissolved in distilled water. Ammonium dihydrogen phosphate (Sigma Aldrich) was added dropwise into the calcium nitrate solu-
tion under continuous stirring. In parallel, the viscous polyurethane-diol solution was dis-
solved in water, and thus obtained solution was transferred into the initial vessel along 
with the other reagents. A precipitate was obtained whose pH was adjusted to 10 using 25% 
ammonia solution. In the second step, the hybrid precursor thus resulted was transferred to 
the Berghof autoclave, Germany and subjected to hydrothermal treatment at a pressure of 
100 bar and a temperature of below 120°C for 3 hours. Pressure is created above the solu-
tion vessel of the autoclave using an argon gas bottle [93, 94]. After hydrothermal treatment, 
the nanostructured powder was washed with distilled water until neutral pH was reached, 
mixed with polyvinyl alcohol (PVA) 5% solution and spray dried in LabPLANT, United 
Kingdom spray dryer.
2.6.2. Hydrothermal synthesis at 1000 bar isostatic pressure
In a first step, Ca(NO3)2*4H2O (Sigma Aldrich) was dissolved in distilled water. Ammonium dihydrogen phosphate (Sigma Aldrich) was added dropwise into the calcium nitrate solu-
tion under continuous stirring. In parallel, the viscous polyurethane-diol solution was dis-
solved in water, and thus obtained solution was transferred into the initial vessel along 
with the other reagents. A precipitate was obtained whose pH was adjusted to 10 using 
25% ammonia solution. In the second step, the hybrid precursor thus resulted was trans-
ferred to the high pressure autoclave HP Systems, France and subjected to hydrothermal 
treatment in isostatic pressure conditions (1000 bar) and a temperature below 120°C, for 
3 hours. Isostatic pressure is created uniformly inside the autoclave by a hydraulic system. 
Figure 2. 3D printed scaffolds using three types of nozzles: (a) Ø 0.8 mm; (b) Ø 0.6 mm; and (c) Ø 0.4 mm [95].
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The reaction mixture is perfectly sealed in a special synthesis bag, leading to formation of 
nanohybrids in microbiologically safe conditions.
After hydrothermal treatment, the nanostructured hybrid powder was washed with dis-
tilled water to a pH of 7, mixed with polyvinyl alcohol (PVA) 5% solution and spray dried in 
LabPLANT, United Kingdom spray dryer.
2.7. Structural characterization
2.7.1. Chemical analysis
Nanostructured hydroxyapatite-polyurethane hybrid powders were characterized by 
chemical quantitative analysis. Ca content was determined using Flame Atomic Absorption 
Spectrometry (FAAS) method. P content was measured using Inductively Coupled Plasma 
Optical Emission Spectrometry (ICP-OES) method according to ASTM E 1479/2011.
Ca and P content of some investigated hybrid samples is presented in Table 2.
Results presented in Table 2 confirmed the formation of hydroxyapatite as the major phase of 
nanostructured powders, namely: Ca:P molar ratio is between 1.54 and 1.75, while in HPU-4 
and HPU-8 samples is equal to theoretical value from pure hydroxyapatite.
2.7.2. FT-IR analysis
Powders characterization using Fourier transform infrared spectroscopy (FT-IR) revealed the 
presence of the following vibration bands: (i) the OH stretching vibration at 3550 cm−1 (sharp 
band) in the HA sample. In the HA-PU hybrid sample the intensity of this band is highly dimin-
ished; (ii) stretching vibration of the water molecule (3300 cm−1). It is a broad band, seen in 
both the HA sample and the hybrid sample; (iii) the deformation vibration of the –OH group 
(1630 cm−1) from HA, which completely disappears in the case of HA-PU sample. This, corre-
lated with the decrease of the OH band at 3350 cm−1, could be due to the interaction of the two 
components through the hydroxyl group; (iv) stretching vibrations of (PO
4
)3-group at 1094, 
Sample name Sample type Ca, % P, % Ca:P molar ratio (calculated)
HPU-1 80% HA-20% PU 32.9 16.2 1.58
HPU-2 80% HA-20% PU 35.6 17.4 1.59
HPU-4 80% HA-20% PU 35.3 16.5 1.66
HPU-5 50% HA-50% PU 35.2 17.8 1.54
HPU-6 80% HA-20% PU 28 12.5 1.75
HPU-7 50% HA-50% PU 38.4 17.1 1.74
HPU-8 80% HA-20% PU 37 17.1 1.67
Note: The bold values represents the experimental molar ratio equivalent to theoretical values hydroxyapatite.
Table 2. Chemical analysis results.
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Figure 3. FT-IR spectra of one hybrid sample compared to pure hydroxyapatite.
1040 and 962 cm−1, being characteristic for hydroxyapatite spectrum (IR fingerprint), can also be 
observed in the hybrid spectrum. The FT-IR spectra of the analyzed powders (hydroxyapatite, 
respectively hydroxyapatite-polyurethane based hybrids) are shown in Figure 3.
2.7.3. Thermal analysis (DSC-TG)
Powders characterization using thermal analysis (DSC-TG) revealed the presence of sev-
eral endothermic peaks, as shown in Table 3. Figures 4 and 5 show thermal analyses of HA 
and HA hybrid samples. Peak 1 could be attributed to the elimination of surface adsorbed 
water. Peak 2, observed only for HPU hybrid powder, could correspond to the removal of 
OH groups from water of constitution. Peak 3 in the hybrid sample, although characterized 
by a very low enthalpy (0.251 J/g), could be associated with breakage of polyurethane chain 
links. Peak 4 (466°C) of the HPU sample corresponds to the decomposition of soft polyure-
thane segments. The last two peaks of the hybrid sample are due to the burning of the organic 
phase. The total mass loss is 14.5%, which means that the polyurethane from the composition 
of HPU sample has almost completely decomposed. Endothermic peaks at 276 and 336°C 
observed in the case of hydroxyapatite (HA sample) can be explained by decomposing of the 
polyvinyl alcohol traces left after drying the sample in the spray dryer. The weight loss for 
the HA sample is 8.5%.
2.7.4. Particle size distribution by DLS technique
Particle size distribution determination with Malvern Zetasizer ZS90 granulometer is based on 
a non-invasive dynamic light scattering (DLS) emitted by a laser. The particle assimilated with 
a sphere is constantly displaced by Brownian motion as a result of statistical collisions with 
the liquid molecules. In this movement, small particles will move faster than large particles. 
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Sample name Peak 1 (endothermic) Peak 2 (endothermic) Peak 3 (endothermic) Peak 4 (endothermic) Peak 5 (endothermic) Peak 6 (endothermic)
T, °C ΔH, J/g T, °C ΔH, J/g T, °C ΔH, J/g T, °C ΔH, J/g T, °C ΔH, J/g T, °C ΔH, J/g
HA 58.1 32.019 – – 276.1 11.963 336.4 21.498 – – 825.6 13.61
HPU 63.5 49.549 135.8 4.429 246.2 0.251 466.6 4.746 711.4 6.226 784 38.762
Table 3. Results obtained from thermal analysis (DSC-TG).
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Figure 4. DSC graph and mass loss of pure hydroxyapatite.
Figure 5. DSC-TG graph and mass loss of one hybrid sample.
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The particle size distribution obtained by DLS is a function of the relative intensity of light 
scattered by particles of different dimensional classes. The time dependence of the intensity 
fluctuations for the determination of the translational diffusion coefficient (D), as well as the 
hydrodynamic diameter (D
H
) are measured by using equation (1). η is the viscosity of the inves-
tigated suspension.
  D 
H
  =  kT _____ 3𝜋𝜂D (1)
The result is a distribution of intensity.
Sample preparation: stable, aqueous dispersions with known optical properties (required for 
size measurement) are prepared. Results are presented in Table 4 and Figure 6.
It can be observed a decrease in the mean particle size of the hybrid material compared to 
pure hydroxyapatite, both for the filtered and the initial samples.
There is a slight tendency for agglomeration of the hybrid material (Figure 6).
Sample name Mean particle size 
[nm]
Polydispersity index Observations
HA 167.5 0.133
HA filtered 146.3 0.061 Sample filtered through Millipore 
membrane (d = 0.22 μm)
HPU 119.7 0.238
HPU filtered 64.65 0.229 Sample filtered through Millipore 
membrane (d = 0.22 μm)
Table 4. DLS analysis results.
Figure 6. Particle size distribution of one hybrid sample filtered through 0.22 μm Millipore membrane.
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2.7.5. HRTEM analysis
HRTEM analysis was performed with a High Resolution Transmission Electron Microscope 
(HRTEM) Tecnai F30, G2S Twin (1 Å line resolution) – FEI Company.
It can be observed rod like structures of hydroxyapatite inside hybrid structure, typical for 
hydrothermally prepared HA, as well diffraction lines which confirms sample crystallinity 
(Figure 7).
EDX spectrum (Figure 8) reveals Ca, P, O and C content of the investigated sample, in accor-
dance with chemical analysis results. Moreover, it confirms the presence of organic phase 
(polyurethane), through C and O content.
Figure 7. TEM images for one hybrid sample with 80% HA and 20% PU.
Figure 8. EDX spectra of one hybrid sample with 80% HA and 20% PU.
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2.8. Biocompatible properties
MSC cells were characterized in terms of their multipotent potential, demonstrating their 
ability to differentiate in vitro into adipocytes and osteoblasts (Figure 9). Dilutions tested 
were: 1/10, 1/20, 1/50, 1/100 and 1/200. Diluted solutions were added to both cultured fresh 
cells and after they were maintained at 37°C under 5% CO
2
 (pH equilibration). Also, for each 
condition, cell interaction studies were performed in culture, both 24 hours after cell adhesion 
and 48 hours after cell adhesion (assuming that in the first case we can see the effect of HAp 
on cellular proliferation, and in the latter case, HAp effect on cell viability).
3. Conclusion
The current chapter deals with the various fabrication methodologies of biomimetic and 
bioactive scaffolds that can be employed for the tissue engineering applications. Biomimetic 
nanocomposites scaffolds have the ability to mimic the structural and mechanical properties 
of native tissues. Various fabrication methodologies are available to replicate and produce 
the biomimetic biomaterials for tissue engineering applications. Various advantages and dis-
advantages of these fabrication methodologies are discussed here. Different classes of mate-
rials are used for biomimetic applications and designing of these biomimetic materials are 
cited with examples. Recent advances and research on scaffolds with controlled nano/micro 
architecture, pore distribution and pore density reveal the potential of the nanocomposites 
Figure 9. Optical microscopy illustrating the ability of human MSC to generate osteoblasts (up) and adipocytes (down) 
in vitro. UP: (left) Human MSC cultivated in normal growth medium (DMEM + 10% SBF-MSC qualified) and von Kossa 
stained; (Middle and right) human MSCs increased 2 weeks in osteogenic differentiation environment; The formation 
of aggregates strongly colored with silver nitrate is observed (von Kossa method). Down: (left) Human MSC cultured 
in normal growth medium (DMEM + 10% SBF-MSC qualifies) and stained with Oil Red O; (Middle and right) human 
MSCs increased 2 weeks in adipogenic differentiation environment; There is evidence of accumulation of red-colored 
lipid charges with Oil Red O.
Fabrication Methodologies of Biomimetic and Bioactive Scaffolds for Tissue Engineering...
http://dx.doi.org/10.5772/intechopen.70707
23
for tissue engineering applications. Technologies such as additive manufacturing, electros-
pinning and other combined recent advanced manufacturing technologies holds promise for 
new advances in the field of tissue engineering. Due to space constraints the present chapter 
has given one of the examples of the possibility to fabricate biomimetic materials by additive 
manufacturing. Further developments are required in the field of biomaterials fabrication to 
exactly replicate the biomimetic conditions.
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